Pinned post
💡 Access to medicines starts with access to information.
🤝🏽 For the past decade, MedsPaL has helped governments, procurement agencies, manufacturers, researchers and public health organisations navigate complex patent and licensing landscapes by making critical information freely available and easier to access.
🌐 Since its launch in 2016, MedsPaL has expanded from around 4,000 patent applications covering three disease areas to a global resource containing information on 217 health products, 33,800 patent applications and 86 public licences across 203 jurisdictions.
🎂 As MedsPaL marks its 10th anniversary, we're proud to reflect on how transparency can support informed decision-making and help advance access to health technologies around the world.
🙏🏽 We're grateful to the many organisations and individuals who have contributed to MedsPaL's development over the past decade, and to our funders and supporters, including @UNITAID, @SwissDevCoop, Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH, the Government of Japan, and @coeff_giving, whose contributions help sustain and strengthen MPP's patent information activities.
🗞️ Read our anniversary statement and discover how @DrDuneton (Unitaid), @JayasreeKIyer (@AtMIndex), @Peter_Beyer (Global Antibiotic R&D Partnership (@gardp_amr), Harm Veerkamp (@IDA_Foundation) Nikola Trifunovic (i+solutions), Jithu Krishnan J (@SunPharma_Live), Viktor Cherniavskyi (@UNDP Global Health Supply Centre), Marion (Amy) Dietterich (@WIPO World Intellectual Property Organization), and @lorenzomoja (@WHO) have used and supported MedsPaL throughout its journey.
🔗 lnkd.in/eX4B4but
Access MedsPaL > medspal.org
#MedsPaL #AccessToMedicines #GlobalHealth #PublicHealth #HealthInnovation
🤝🏽 For the past decade, MedsPaL has helped governments, procurement agencies, manufacturers, researchers and public health organisations navigate complex patent and licensing landscapes by making critical information freely available and easier to access.
🌐 Since its launch in 2016, MedsPaL has expanded from around 4,000 patent applications covering three disease areas to a global resource containing information on 217 health products, 33,800 patent applications and 86 public licences across 203 jurisdictions.
🎂 As MedsPaL marks its 10th anniversary, we're proud to reflect on how transparency can support informed decision-making and help advance access to health technologies around the world.
🙏🏽 We're grateful to the many organisations and individuals who have contributed to MedsPaL's development over the past decade, and to our funders and supporters, including @UNITAID, @SwissDevCoop, Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH, the Government of Japan, and @coeff_giving, whose contributions help sustain and strengthen MPP's patent information activities.
🗞️ Read our anniversary statement and discover how @DrDuneton (Unitaid), @JayasreeKIyer (@AtMIndex), @Peter_Beyer (Global Antibiotic R&D Partnership (@gardp_amr), Harm Veerkamp (@IDA_Foundation) Nikola Trifunovic (i+solutions), Jithu Krishnan J (@SunPharma_Live), Viktor Cherniavskyi (@UNDP Global Health Supply Centre), Marion (Amy) Dietterich (@WIPO World Intellectual Property Organization), and @lorenzomoja (@WHO) have used and supported MedsPaL throughout its journey.
🔗 lnkd.in/eX4B4but
Access MedsPaL > medspal.org
#MedsPaL #AccessToMedicines #GlobalHealth #PublicHealth #HealthInnovation